Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Mark Atkinson
University of Florida, Department: Md Pathology General
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kairos Ventures
This is a VC company based out of California. They are evaluating a method for preventing diabetes involving gene therapy by using lentiviral vectors carrying genes for anti-apoptotic activities OR modulating islet endocrine function. This, to be delivered by intra-pancreatic injection. The inventor of the technology is a well respected type 2 diabetes person (Dr. Ralph Defronzo) BUT, they say it is for type 1 diabetes. Hence, I believe this to be a one off review on my part...as I see many issues as problematic, at least up front. But, need to see their confidential materials to know for certain.
By phone conferance, max 8 hours.
Filed on November 21, 2017.
Tell us what you know about Mark Atkinson's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Mark Atkinson”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Mark Atkinson | University of Florida | Financial Disclosure | T1D Capital LP | |
| Mark Atkinson | University of Florida | Financial Disclosure | OneVax LLC | |
| Mark Atkinson | University of Florida | Financial Disclosure | Nirmidas Biotech | |
| Mark Atkinson | University of Florida | Financial Disclosure | Pancreum | |
| Mark Atkinson | University of Florida | Financial Disclosure | Merck | |
| Mark Atkinson | University of Florida | Financial Disclosure | Medimmune, Inc | |
| Mark Atkinson | University of Florida | Financial Disclosure | Tenacia | |
| Mark Atkinson | University of Florida | Financial Disclosure | GlaxoSmithKline | |
| Mark Atkinson | University of Florida | Financial Disclosure | IM Therapeutics |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.